Skip to content

Vera Therapeutics VERA Other Non-Current Assets

Other Non-Current Assets at other companies

Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$8.48M-54.6%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$93K-88.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$11.24M+108%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$888K+81.6%
Immunome logo
ImmunomeIMNM
$5.36M+23.4%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$8.29M+1,846%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's other non-current assets?
Vera Therapeutics (VERA) reported other non-current assets of $5.94M in Q1 2026.
How has Vera Therapeutics's other non-current assets changed year-over-year?
Vera Therapeutics's other non-current assets increased by 493.7% year-over-year, from $1M to $5.94M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.